$14.410
+0.285 (+1.98%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NPCE Prediction & Forecast by Similar Chart Analysis
Alphio's NPCE stock price prediction model matches the current Neuropace Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.29 (-0.84%). The 1-week path is $14.41 (-0.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Neuropace Inc Stock?
Neuropace Inc is a good buy right now due to its current price of $14.41 being significantly below analyst targets, with Mizuho projecting a price of $22, indicating a potential upside of over 52%. Additionally, the company's gross margin has improved to 82.83% in Q2 2026, showcasing strong profitability potential. However, the main risk is the FDA denial for the RNS system expansion, which could impact revenue growth projections, particularly as the company anticipates a revenue range of $99 million to $101 million for 2026, which could be affected by this setback.
NPCE stock price ended at $14.41 on Friday, after rising +1.98%
Neuropace Inc (NPCE) last closed at $14.41, gaining +1.98%. These facts feed the 1-day and 1-week NPCE price prediction above.
Forecast Drivers
Neuropace Inc (NPCE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NPCE, ranked by similarity.
Seasonality analysis for NPCE
Historically the probability of a positive August return for NPCE is 0.00%. December offers the highest probability of a positive month at 100.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NPCE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $15.07 | $17.43 | $19.34 | +20.98% |
| Sep 2026 | $17.17 | $17.54 | $21.22 | +21.72% |
| Oct 2026 | $14.20 | $14.75 | $18.13 | +2.38% |
| Nov 2026 | $10.20 | $12.85 | $16.25 | -10.83% |
| Dec 2026 | $16.30 | $17.12 | $19.11 | +18.78% |
In 2026, Neuropace Inc (NPCE) is projected to range from $10.20 to $21.22.
Neuropace Inc 2026 monthly forecast
In Aug 2026, Neuropace Inc is projected to average $17.43, with a low of $15.07 and high of $19.34.
In Sep 2026, Neuropace Inc is projected to average $17.54, with a low of $17.17 and high of $21.22.
In Oct 2026, Neuropace Inc is projected to average $14.75, with a low of $14.20 and high of $18.13.
In Nov 2026, Neuropace Inc is projected to average $12.85, with a low of $10.20 and high of $16.25.
In Dec 2026, Neuropace Inc is projected to average $17.12, with a low of $16.30 and high of $19.11.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。